PETS
PetMed Express, Inc.
Healthcare · Pharmaceutical Retailers · NMS
$1.68
Data: 2026-05-22
✗ ETHICAL FAIL
MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$46M
Total market value of the company
0.00
Rev Growth
-21.7%
Year-over-year revenue change
Profit Margin
-34.7%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About PetMed Express, Inc.
Company description not available.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
1.4% PASS
Debt must be below 33% of total assets
Cash Ratio
58.3% FAIL
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
-27.1%
Historical annualised return based on price data
Days in State
89
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-30 | FULGONI GIAN M | Director | 33,846 | — | |
| 2025-10-30 | MENNEN JUSTIN L. | Director | 33,846 | — | |
| 2025-10-30 | LACAMP JAMES | Director | 34,866 | — | |
| 2025-10-30 | SOLIVAN LEAH A. | Director | 33,846 | — | |
| 2025-10-30 | BATUSHANSKY PETER | Director | 33,846 | — | |
| 2025-10-30 | KRULIK DOUGLAS | Chief Financial Officer | 20,000 | — | |
| 2025-09-09 | KRULIK DOUGLAS | Officer | 10,000 | — | |
| 2025-08-13 | SILVERCAPE INVESTMENTS LTD. | Beneficial Owner of more than 10% of a Class of Security | 101,000 | $320,170 | |
| 2025-08-01 | SILVERCAPE INVESTMENTS LTD. | Beneficial Owner of more than 10% of a Class of Security | 118,200 | $379,422 | |
| 2025-07-21 | NINA CAPITAL HOLDINGS INC | Beneficial Owner of more than 10% of a Class of Security | 25,000 | $87,425 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-22